β细胞功能的保存。 - Suppr

Suppr

超能文献

Preservation of beta cell function.

作者信息

Sperling Mark A

机构信息

Children's Hospital of Pittsburgh of UPMC and The University of Pittsburgh School of Medicine Pittsburgh, PA, USA.

出版信息

Pediatr Diabetes. 2010 May;11(3):152-3. doi: 10.1111/j.1399-5448.2010.00675.x.

DOI:10.1111/j.1399-5448.2010.00675.x

PMID:20546532

Abstract

摘要

相似文献

Preservation of beta cell function.

Pediatr Diabetes. 2010 May;11(3):152-3. doi: 10.1111/j.1399-5448.2010.00675.x.

Immunotherapy of type 1 diabetes.

Arch Immunol Ther Exp (Warsz). 2008 Jul-Aug;56(4):227-36. doi: 10.1007/s00005-008-0025-2. Epub 2008 Jul 29.

Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.

Diabetes Technol Ther. 2013 Jun;15 Suppl 2(Suppl 2):S2-13-S2-20. doi: 10.1089/dia.2013.0107.

[Antibodies instead of insulin?].

Pharm Unserer Zeit. 2010 Mar;39(2):97-8. doi: 10.1002/pauz.201090017.

B cell therapy is β-tested: Rituximab puts a pause on β-cell destruction.

Islets. 2010 Mar-Apr;2(2):130-2. doi: 10.4161/isl.2.2.11452.

[Recent advances in the treatment of type 1 diabetes mellitus].

Dtsch Med Wochenschr. 2011 Feb;136(5):172-5. doi: 10.1055/s-0031-1272502. Epub 2011 Jan 26.

A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice.

Diabetes. 2016 May;65(5):1310-6. doi: 10.2337/db15-0492. Epub 2015 Dec 30.

Tackling type 1 diabetes: new immune-modulating drugs attack the root cause.

Chem Biol. 2007 Dec;14(12):1305-6. doi: 10.1016/j.chembiol.2007.12.005.

[C-peptide residual secretion makes difference on type 1 diabetes management?].

Arq Bras Endocrinol Metabol. 2008 Mar;52(2):322-33. doi: 10.1590/s0004-27302008000200020.

Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture.

Diabetes. 2018 Sep;67(9):1701-1709. doi: 10.2337/dbi18-0025.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Preservation of beta cell function.

Pediatr Diabetes. 2010 May;11(3):152-3. doi: 10.1111/j.1399-5448.2010.00675.x.

Immunotherapy of type 1 diabetes.

Arch Immunol Ther Exp (Warsz). 2008 Jul-Aug;56(4):227-36. doi: 10.1007/s00005-008-0025-2. Epub 2008 Jul 29.

Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.

Diabetes Technol Ther. 2013 Jun;15 Suppl 2(Suppl 2):S2-13-S2-20. doi: 10.1089/dia.2013.0107.

[Antibodies instead of insulin?].

Pharm Unserer Zeit. 2010 Mar;39(2):97-8. doi: 10.1002/pauz.201090017.

B cell therapy is β-tested: Rituximab puts a pause on β-cell destruction.

Islets. 2010 Mar-Apr;2(2):130-2. doi: 10.4161/isl.2.2.11452.

[Recent advances in the treatment of type 1 diabetes mellitus].

Dtsch Med Wochenschr. 2011 Feb;136(5):172-5. doi: 10.1055/s-0031-1272502. Epub 2011 Jan 26.

A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice.

Diabetes. 2016 May;65(5):1310-6. doi: 10.2337/db15-0492. Epub 2015 Dec 30.

Tackling type 1 diabetes: new immune-modulating drugs attack the root cause.

Chem Biol. 2007 Dec;14(12):1305-6. doi: 10.1016/j.chembiol.2007.12.005.

[C-peptide residual secretion makes difference on type 1 diabetes management?].

Arq Bras Endocrinol Metabol. 2008 Mar;52(2):322-33. doi: 10.1590/s0004-27302008000200020.

Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture.

Diabetes. 2018 Sep;67(9):1701-1709. doi: 10.2337/dbi18-0025.